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Abstract 
The purpose of this study is to evaluate the probiotic characteristics of 15 yeast strains isolated from nectar of toddy 
palm. Initially, the collected samples were inoculated on yeast extract peptone dextrose agar plates and the colonies 
so obtained were culturally and morphologically characterized. Commercial probiotic yeast, Saccharomyces boular-
dii served as the control in these experiments. Of the 15 yeast strains, the isolates that were resistant to antibiotics 
and worked synergistically with other cultures were considered for further evaluation. Selected isolates were evalu-
ated in vitro for tolerance to simulated gastrointestinal conditions such as temperature, pH, bile and gastric juice. 
Further the yeast isolates were evaluated for their pathogenicity and adherence to intestinal epithelial cells. The 2 
yeast isolates with efficient probiotic properties were finally characterized by sequencing their 5.8 S rRNA and partial 
sequences of internal transcribed spacer 1 and 2. The sequences were BLAST searched in the National Center for 
Biotechnology Information, nucleic acid database for sequence similarity of organisms and phylogenetic evolution-
ary analysis was carried out. Based on maximum similarity of basic local alignment search tool results, organisms were 
characterized as Pichia kudriavzevii OBS1 (100%) and Saccharomyces cerevisiae OBS2 (96%) and sequences were finally 
deposited in the GenBank data library. Among these two isolates, S. cerevisiae OBS2 displayed slight/moderate antioxi-
dant and anticancer property. Hence, strain OBS2 can be utilized and explored as a potential probiotic for therapeutic 
applications.
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Introduction
It is well known that many types of bacteria and yeast 
strains are being used to enhance the fermentative reac-
tions in food industries including bread, beer, wine and 
xylitol (Ortiz et  al. 2013). Besides fermentation, these 
organisms are playing numerous beneficial roles in 
human, animal health and nutrition. A number of previ-
ous studies reported about the use of probiotics for the 
prevention and treatment of gastrointestinal infections 
including food borne pathogens associated infections 
(Fooks and Gibson 2002). In addition, it is reported that 
yeast promotes both human and animal health (Zanello 
et al. 2009; O’Neil et al. 2012) and enhances the bioavail-
ability of minerals through hydrolysis of phytate, folate 
biofortification, detoxification of mycotoxins and xenobi-
otics (Ohashi and Kazunari 2009). At present, the prod-
ucts of wild and recombinant yeast form the backbone for 
many commercially important sectors, including foods, 
beverages, pharmaceuticals, industrial enzymes and 
medicine (Mc Meekin et  al. 1997). Saccharomyces cer-
evisiae has a Qualified Presumption of Safety (QPS) sta-
tus (Verna and Lucak 2010; Waters et al. 2012). Potential 
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probiotic mechanism of S. cerevisiae is based on emission 
of inhibitory proteins against pathogens, stimulation of 
host immunoglobulin A and exclusion of secreted toxins 
in host intestine (Fooks and Gibson 2002).
Tolerance to low pH, high temperature, high ox-bile 
concentration, a mixture of organic acids concentra-
tion, digestive enzymes like amylase, pepsin and trypsin 
concentrations and ability to produce several other use-
ful metabolites represent the beneficial characteristics 
of probiotics (Fridkin and Jarvis 1996). Probiotics need 
to survive the inevitable biological barriers of the gut. 
It is evidently proven from the previous in vitro studies 
that eukaryotic probiotics can tolerate the well simulated 
environmental conditions of the digestive tract (Kumura 
et al. 2004). The probiotic strains of S. cerevisiae are not 
only able to survive in the digestive tract of the host, but 
also found to persist at high populations (Blehaut et  al. 
1989). The pharmacokinetic studies indicate that the 
probiotic Sachcharomyces var boulardii when ingested 
orally achieved a steady state in the gut within 3 days, but 
eliminated within 2–5 days after it is discontinued. Such 
elimination from the digestive tract is believed to be due 
to the barrier effect of the complex established by resi-
dent microbiota of the gut (Fridkin and Jarvis 1996; Yoo 
and Kim 2016).
Yeast with its derivatives or by-products has gained 
huge importance and become a model organism for many 
biological functions in our life. S. cerevisiae is a potential 
organism to be explored as novel natural anticancer, anti-
oxidant and immunostimulating agent for using in func-
tional foods or medicine (Hassan 2011; Balasubramanian 
and Ragunathan 2012).
Since the droppings and exudates of toddy palm dur-
ing hot summer stimulate the growth of simple sugar 
fermenting, high temperature (~40 °C) resistant microor-
ganisms (Abdel Fattah et al. 2000), in the present study, 
yeasts were isolated from fermented nectar of toddy 
palm. The isolated yeast samples were subjected to a 




Samples were collected from naturally fermented nectar 
of toddy palm during mid day of hot summer (~40  °C) 
from different regions of Telangana State, India. Com-
mercial probiotic yeast S. boulardii (Econorm, Dr. 
Reddy’s Laboratories, Hyderabad, India) was used as a 
referral organism.
Isolation of yeasts was carried out by using stand-
ard methodology described by Tikka et  al. (2013) and 
Zaky et  al. (2014). After incubation, colonies were 
selected based on morphology and sub-cultured on yeast 
extract peptone dextrose (YPD) agar slants for further 
observations.
Growth and characterization of yeast isolates
Isolates were characterized by their cultural and mor-
phological characteristics following the protocols as 
described by Reis et al. (2013). After incubation, cultural 
and morphological characteristics were observed by 
visible growth pattern followed by simple staining and 
microscopic observation.
The sugar utilization ability of yeast isolates was 
achieved by their sugar assimilation profiling. The sugar 
assimilation property enables us to determine the abil-
ity of yeast to use a specific sugar/carbohydrate as a sole 
source of carbon. Yeast nitrogen base (YNB) medium 
with 2% (w/v) specific selected sugar (s) like glucose, 
maltose, ribose, fructose, xylose, cellobiose, dextrose, 
mannose, starch, sucrose, lactose and galactose were 
used for determination of yeast sugar assimilation prop-




The yeast isolates were tested for antimicrobial drug sen-
sitivity against 8 antifungal agents like Cefmetazole 30 µg 
(CMZ 30), Ceftazidime 10  µg (CTR 10), Clotrimazole 
10 µg (CC 10), Fluconazole 10 µg (FLC 10), Itraconazole 
10 µg (IT 10), Ketoconazole 50 µg (KT 50), Miconazole 
50  µg (MIC 50) and Nystatin 100  µg (NS 100) and 20 
antibacterial agents like Amoxicillin 10  µg (AMX 10), 
Ampicillin 10 µg (AMP 10), Ampicillin 25 µg (AMP 25), 
Bacitracin 10 µg (B 10), Ceftriaxone 10 µg (CT 10), Chlo-
ramphenicol 10  µg (C 10), Clindamycin 10  µg (CD 10), 
Cloxacillin 10 µg (COX 10), Enrofloxacin 10 µg (EX 10), 
Erythromycin 10 µg (E 10), Gentamicin 10 µg (GEN 10), 
Kanamycin 30 µg (K 30), Lincomycin 10 µg (L 10), Methi-
cillin 10 µg (MET 10), Neomycin 10 µg (N 10), Norfloxa-
cin 10 µg (NX 10), Penicillin G 10 µg (P 10), Streptomycin 
10 µg (S 10), Streptomycin 25 µg (S 25), Teracycline 10 µg 
(TE 10), Teracycline 30 µg (TE 30), Trimethoprim 10 µg 
(TR 10) and Vancomycin 10 µg (VA 10) of Sigma Aldrich 
(Sigma Aldrich Pvt. Ltd., India) were placed on yeast 
inoculated YPD medium plates and incubated for 48 h at 
30  °C. After incubation drug sensitivity of the yeast iso-
lates was evaluated by measuring the zone of inhibition 
(Mashad et al. 2012).
Antagonistic activity against pathogens
Antagonistic activity of yeast isolates was evaluated by 
agar well plate method by measuring the zone of inhi-
bition around the wells as per protocol described by 
Sibanda et al. (2010) against human intestinal pathogenic 
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bacteria like Escherichia coli 0157:H7, Pseudomonas aer-
uginosa, Klebsiella pneumonia, Staphylococcus aureus, 
Salmonella typhi and Salmonella paratyphi.
Co‑culture activity with healthy commensals
Co-culture activity assay is yet another method to deter-
mine the positive or negative impact and/or ability of 
candidate probiotic yeast isolates to coexist with normal 
bacterial flora of the human intestine. Yeast isolates and 
bacterial cultures like E. coli 0150:H5, Lactobacillus aci-
dophilus were activated in their basal media and equal 
volumes (0.1 ml) of their suspensions were inoculated in 
a modified medium (1% yeast extract, 1% peptone, 0.25% 
NaCl and 1% dextrose) with pH 6.5 and incubated at 
37 °C for 24 h. After incubation, culture suspensions were 
diluted to tenfold and 10 µl of 10−3 dilution was inocu-
lated on YPD agar medium with Ampicillin (30  µg/ml), 
Kanamycin (30 µg/ml) for yeast growth and nutrient agar 
medium with Geneticin (200 µg/ml) for bacterial growth. 
The YPD agar medium plates were incubated at 30 °C for 
48 h and nutrient agar plates were incubated at 37 °C for 
24 h. After incubation, percent viability of yeast isolates 
and bacteria was determined on the basis of colony form-
ing units (CFU) using modified methodology of Paschos 
et al. (2015).
Stress tolerance
A crucial step towards the identification and selection of 
potential probiotic candidates is to evaluate their resist-
ance to the extreme conditions of the gastrointestinal 
tract. The barriers that must be overcome are tempera-
ture, low pH, organic acids and digestive enzymes, i.e. 
pepsin and amylase in the stomach and trypsin and bile 
in the upper intestine (Corzo and Gilliland 1999). The 
probiotic organism should be able to tolerate high tem-
perature, i.e. above 37  °C and the diverse conditions 
of the gastric juice. Therefore, to test the parameters of 
stress tolerance of yeast isolates the following experi-
ments were performed.
Resilience to gastrointestinal parameters
Actively growing yeast suspensions (1  ml) were inocu-
lated in 100 ml phosphate buffered saline (PBS) and incu-
bated for 4  h at different temperatures (30, 37, 40 and 
45 °C), with different pH (2.0, 2.5, 3.0 and 3.5), different 
percentages of ox bile (0.25, 0.5, 0.75 and 1.0) and dif-
ferent percent mixture of 3 organic acids like propionic, 
butyric and acetic acids in 7:2:1 ratio (0.25, 0.5, 0.75 and 
1.0). After incubation, 100 µl of inoculum from each set 
was inoculated on YPD agar at 30 °C for 24 h and percent 
tolerance was calculated by using the formula (log N/log 
N0) ×  100 where N is count after incubation and N0 is 
count before incubation (both expressed as cfu/ml) (Syal 
and Vohra 2013).
Aqueous solution (1 ml) of 5% NaCl was taken to cre-
ate an in vitro gastric environment with different concen-
trations of enzymes like Pepsin (2.0, 4.0, and 6.0  g  l−1), 
Trypsin (0.25, 0.5 and 0.75 mg ml−1) and Amylase (250, 
300 and 350  IU  ml−1) (Pennacchia et  al. 2008). The pH 
of pepsin containing solution was adjusted to 2.0 and 
trypsin and amylase containing solution was adjusted to 
7.5. All the sets were inoculated with 0.1% inoculum of 
yeast isolates and incubated at 30 °C in a shaking incuba-
tor at 150  rpm for 4  h. After incubation of all the sets, 
100 µl of inoculum from each set was inoculated on YPD 
agar medium for the determination of percent tolerance 
of yeast isolates (Syal and Vohra 2013).
Pathogenicity of yeast isolates
Yeast such as S. boulardii are best studied probiotics 
being used successfully and well known to play a crucial 
role in the treatment and management of diarrhoea and 
inflammatory bowel disease and to reduce the duration 
of disease. Despite an excellent record of safe use, yeasts 
may still be the cause of localized infections in some 
patients.
Therefore, in order to determine whether the yeast 
isolates show pathogenicity, it was studied by the detec-
tion of enzymes like protease, phospholipase, the ability 
of haemolysis and by detection of specific pathogenic 
genes through polymerase chain reaction (PCR) ampli-
fication. Protease activity was tested using milk casein 
and gelatin as substrates by the method described by 
Lechuga et  al. (2016) and was adapted to verify the 
phospholipase activity. Similarly, haemolytic activity 
was determined by a modified method of Manns et  al. 
(1994). Protease and phospholipase production was 
detected by halos formation around the culture and 
haemolysin activity was detected by measurement of 
haemolytic index (Luo et  al. 2001). Extracted genomic 
DNA of each isolate was amplified with universal primer 
SR6R (5′-AAGTAAAGT-CGTAACAAGG-3′) and LR1 
(5′-GGTTGGTTTCTTTTCCT-3′) of human patho-
genic Candida albicans. The reaction mixture for PCR 
and conditions are as per protocol described by Koehn 
(1982). The amplicons formed as PCR product were visu-
alized on an agarose gel.
Cell adhesion
Caco-2 cells derived from human intestinal epithelial 
cells were purchased from National Centre for Cell Sci-
ence (NCCS), Pune, India and maintained in Eagle’s min-
imal essential medium (MEM) with glutamine (0.584 g/l), 
sodium bicarbonate (3.7  g/l), penicillin (100 U/ml), 
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streptomycin (100 µg/ml), and 5% serum and the final pH 
of medium was adjusted to 7.2 before sterilization. Cul-
ture flasks with medium were maintained in a CO2 incu-
bator at 37 °C and 5% CO2 as per the protocol described 
in Nikolic et  al. (2012). Inoculated monolayers were 
washed thrice with warm MEM medium without serum. 
Adhesion of yeast cells with monolayer was fixed with 
cold methanol, stained with Giemsa stain and observed 
under microscope for adherence. The mean number of 
yeast cells was determined and the adherence score was 
expressed for each yeast isolate.
Molecular characterization
Based on the probiotic characteristics, 2 yeast iso-
lates OBS1 and OBS2 were selected and characterized 
by sequencing of 5.8S rRNA and internal transcribed 
spacer (ITS) 1 and 2 (Fujita et  al. 2001). Genomic 
DNA was extracted using an Insta Gene Matrix (BIO 
RAD, California, USA). The universal primers used 
for amplification of 5.8S rRNA, ITS1and ITS2 were 
5′-TCCGTAGGTGAACCTGCGG-3′ and 5′-TCCTC-
CGCTTATTGATATGC-3′. The PCR conditions were 
set to 1  min each for denaturation at 95  °C, annealing 
at 55 °C, 2 min for an extension at 72 °C and finally fin-
ishing with a 10 min step at 72 °C. The amplicons were 
purified with a multiscreen filter plate (Millipore Corp., 
Bedford, MA, USA) and sequencing was  performed 
using PRISM BigDye Terminator v3.1 Cycle sequencing 
Kit (Applied Biosystems, California, USA). The ampli-
cons were added to Hi-Di formamide (Applied Biosys-
tems, Foster City, CA) and the mixture was incubated at 
95 °C for 5 min, followed by incubation on ice for 5 min 
and then analyzed by ABI Prism 3730XL DNA analyzer 
(Applied Biosystems). Complete sequence of 5.8S rRNA 
and partial sequences of internal transcribed spacer 
(ITS) 1 and 2 were BLAST searched in NCBI database 
(www.ncbi.nlm.nih.gov) for similarity. Based on maxi-
mum similarity of BLAST results, a phylogenetic den-
drogram was constructed using Phylip 3.69.
Anticancer properties
Three test samples were prepared to assess the cytotoxic 
effect of yeast isolates on the chosen cancer cell lines 
MCF7 (Breast cancer) and IMR32 (Neuroblastoma). 
Among three samples, two were prepared by cultivat-
ing yeast isolates OBS1 and OBS2 separately overnight 
and one without yeast in YPD broth medium. After 
overnight incubation, all the three samples were centri-
fuged to separate yeast cells and supernatants were fil-
tered using membrane filters to obtain clear sterile test 
samples. Sulforhodamine B (SRB) assay was performed 
to assess the anticancer property of yeast isolates (Sza-
jewska et al. 2006). Briefly, 10 × 103 cells in 100 μl Dul-
becco’s modified Eagle medium (DMEM) per well were 
seeded in triplicates in 96-well flat-bottom plates and are 
allowed to adhere overnight. Following this incubation 
period, the filtrate obtained from cultured broth of yeast 
isolates OBS1 and OBS2 were added to each of the wells 
in a volume dependent manner (2–40 µl) and incubated 
for 48 h. After 48 h, the media was replaced with 100 µl 
of 10% Trichloroacetic acid for fixation of cells for 1 h at 
4  °C and stained with 0.4% sulforhodamine B dissolved 
in 1% acetic acid. Cells were then washed with 1% acetic 
acid to remove unbound dye. The protein-bound dye was 
extracted with 10 mM Tris base to determine the optical 
density at 510 nm wavelength.
Antioxidant properties
The yeast autolysate for determination of antioxidant 
activity was prepared as per the protocol described by 
Chana et  al. (2005). Cell pellets of two active yeast iso-
lates, OBS1 and OBS2 were suspended in 20  ml ster-
ile distilled water and incubated at 25 °C for 72 h. After 
incubation, the content was centrifuged and the volume 
of separated supernatant autolysate solution was made 
up to 500 ml with distilled water. The antioxidant activ-
ity of yeast isolates was assayed using phosphomolyb-
denum method (Kumaran and Karunakaran 2007). The 
increased absorbance of reaction mixture indicates the 
increased antioxidant property.
Statistical analysis
Statistical analysis was carried out for the data using the 
Statistical Package for the Social Sciences (SPSS), version 
12.0 for Windows, for the determination of average and 
standard deviations. In this analysis, independent vari-
ables are temperature, pH, ox-bile, organic acid mixture, 
gastric enzymes like amylase, trypsin and pepsin and the 
dependent variables are the percent tolerance of yeast 
isolates. Significance was determined to be p < 0.01 using 
two-way analysis of variance (ANOVA), followed by 
Duncan’s multiple range test.
Sequence and culture deposition
Sequences were submitted to the NCBI GenBank and 
acquired accession numbers for both the strains. OBS1: 
KP998095 and OBS2: KP998094. Based on probiotic 
and therapeutic properties, yeast OBS2 was selected and 
deposited into DSMZ culture collection as S. cerevisiae 
DSM 103642.
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Results
Isolation and associated growth/morphological 
characteristics of yeast strains
A total of 53 yeast isolates (OBS1-OBS53) were isolated 
from the nectar of toddy palm collected from different 
regions of Telangana state of India. The basic idea behind 
this is to enable isolation of yeast strains from differ-
ent hostile environments which will facilitate the func-
tion of isolated strains with plausible efficient probiotic 
characteristics.
Fifteen yeast isolates (OBS1-OBS15) were selected for 
further studies based on their differential growth and 
colony morphology like margin, elevation, color, type of 
fermentation and shape.
The yeast isolate OBS12 showed biomass formation 
upon mannitol supplementation, S. boulardii showed 
biomass formation in Lactose supplemented medium. 
However, all isolates did not form biomass in ribose, cel-
lulose, starch supplemented media. Except OBS9, OBS2 
and OBS4, biomass was observed for all the isolates in 
galactose supplemented medium (Table 1).
Probiotic properties of yeast isolates
Antimicrobial drug sensitivity and antagonistic properties
Fifteen yeast isolates were tested for antimicrobial drug 
susceptibility by disc diffusion method. The results of 
the antimicrobial drug susceptibility of the yeast strains 
OBS1 and OBS2 against 21 antibacterial and 8 antifungal 
drugs are summarized in Fig. 1. All the 15 isolates were 
resistant to the β- lactams cephalosporins i.e. Cefmeta-
zole (30 µg) and Ceftazidime (10 µg); OBS1 and OBS10 
were resistant to the cell wall biosynthesis inhibitor and 
the antifungal agent Clotrimazole (10  µg); S. boular-
dii, OBS4 and OBS10 were resistant to synthetic Tria-
zole  antifungal agent Fluconazole (10  µg); S. boulardii, 
OBS1, OBS2, OBS3, OBS5, OBS10, OBS13 and OBS15 
were resistant to azole antifungal, Itraconazole (10  µg) 
and OBS9 was resistant to Ketoconazole (50 µg), Micona-
zole (50 µg), the azole antifungals and Nystatin, an anti-
mycotic polyene  antibiotic (100  µg). The other isolates 
were sensitive to all the antifungal agents. Yeast isolate 
OBS2 was sensitive to aminoglycosides-Streptomycin 
(10 µg) and Gentamicin (10 µg) with 0.1 and 0.2 cm zone 
of inhibition, respectively whereas OBS1 was sensitive to 
Gentamicin (10  µg) with 0.2  cm zone of inhibition. All 
other isolates were resistant to all antibacterial agents 
and hence did not show any zone of inhibition around 
the disc.
Based on the results of morphological, cultural and 
antimicrobial drug sensitivity profiles, 8 isolates (i.e. 
OBS1, OBS2, OBS4, OBS7, OBS9, OBS11, OBS12 and S. 
boulardii) were selected for further studies.
The results clearly indicate that 12  h grown cultures 
of all the eight yeast isolates and 24 h grown cultures of 
OBS7 and OBS9 did not show any antimicrobial/antag-
onistic activity towards intestinal pathogenic bacteria. 
Pathogenic E. coli 0157:H7 was resistant to S. boulardii 
and OBS4 whereas K. pneumoniae was resistant to 24 h 
grown cultures of OBS1. Bacterial cultures like E. coli 
0157:H7, P. aeruginosa, K. pneumonia, Staph. aureus, 
S. typhi and S. paratyphi were sensitive to yeast isolates 
OBS1 with 0.8, 0.2 0.0, 0.8, 0.3 and 0.8  cm, OBS2 with 
Table 1 Sugar assimilation profile of yeast isolates
A glucose, B fructose, C maltose, D ribose, E dextrose, F mannitol, G cellulose, H starch, I xylose, J sucrose, K lactose, L galactose, M control
(+) indicates presence of biomass and (−) indicates absence of biomass
S. no Isolate A B C D E F G H I J K L M
1 S. boulardii + + + − + − − − + + + + −
2 OBS1 + + + − + − − − + + − + −
3 OBS2 + + + − + − − − + + − − −
4 OBS3 + + + − + − − − + + − + −
5 OBS4 + + − − + − − − + + − − −
6 OBS5 + + + − + − − − + + − + −
7 OBS6 + + + − + − − − + + − + −
8 OBS7 + + + − + − − − + + − + −
9 OBS9 + + + − + − − − + + − − −
10 OBS10 + + + − + − − − + + − + −
11 OBS12 + + + − + + − − + + − + −
12 OBS13 + + + − + − − − + + − + −
13 OBS14 + + + − + − − − + + − + −
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0.5, 0.5, 0.6, 0.8, 0.3 and 0.8 cm, OBS3 with 0.8, 0.3, 0.8, 
0.6, 0.3 and 0.8 cm, OBS4 with 0.0, 0.3, 0.2, 0.5, 0.3 and 
0.8 cm and OBS12 with 1.0, 0.5, 1.0, 1.0, 0.2 and 1.0 cm 
zone of inhibition, respectively (Fig. 2).
Yeast isolates OBS1, OBS2, OBS3, OBS4, OBS7, OBS9 
and OBS12 showed percent cell viability of 78, 85, 81, 
78, 28, 35 and 62, respectively when cultured with E. coli 
0150:H5. Similarly the isolates OBS1, OBS2, OBS3, OBS4, 
OBS7, OBS9 and OBS12 showed percent cell viability of 
53, 82, 25, 28, 25, 26 and 73, respectively when cultured 
with L. acidophilus. Whereas S. boulardii showed 53 per-
cent viability with E. coli 0150:H5 and 62 percent viabil-
ity with L. acidophilus. In none of the above studies cell 
viability of neither E. coli 0150:H5 (86 percent) nor L. aci-
dophilus (84 percent) got affected by yeast isolates.
Stress tolerance
Tolerance to temperature by yeast isolates OBS2 and 
OBS9 was significantly (p  <  0.01) different from other 
isolates at 45  and 40 °C, respectively.. Tolerance observed 
for OBS2 at 45 °C, pH 2, 1 percent ox-bile and 1 percent 
organic acid mixture were 97.66, 92.66, 92.33 and 91.33 
percent, respectively which were significantly (p  <  0.01) 
different from other yeast isolates (Table 2).
The tolerance ability of yeast isolates to various diges-
tive enzymes such as amylase, pepsin and trypsin was 
observed and OBS1, OBS2 and S. boulardii showed bet-
ter tolerance compared to other isolates. However, the 
percent tolerance observed for OBS2 at 350  IU  ml−1 
amylase, 0.75 mg ml−1 trypsin and 6.0 g  l−1 pepsin was 
89.33, 99.33 and 96.66, respectively and significantly 
(p < 0.01) different from other isolates (Table 3).
Among the 7 yeast isolates, OBS1 and OBS2 tolerate 
extreme conditions of the gastrointestinal tract like tem-
perature, low pH, organic acids and digestive enzymes, 
i.e. pepsin and amylase in the stomach and trypsin and 
bile in the upper intestine.
Pathogenicity of yeast isolates
The seven yeast isolates did not show any zone of hydrol-
ysis around the colony on specific media indicating that 
none of the isolates have protease, phospholipase and 
haemolytic activity (Fig. 3). Further, except OBS1, OBS2 
and S. boulardii the template DNA was amplified with 
primers of human pathogenic yeast C. albicans and 
hence were considered as pathogens. The yeast isolates 
OBS1 and OBS2 were considered as non pathogens and 
selected for further studies (Fig. 4).
Cell adhesion
Successful probiotic microorganisms are able to colonize 
by adhering to the intestinal mucosa at least temporar-
ily. Therefore, we determined the adhesion ability of yeast 
isolates by following the protocol as mentioned in mate-
rials and methods. The mean number of yeast cells was 
counted and the adherence score for each of the yeast 
isolate was determined on the basis of size of the inocu-
lum. Among all the yeast isolates, S. boulardii, OBS1 and 
Fig. 1 Antimicrobial drug sensitivity of a yeast isolate OBS2 and b OBS1
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OBS2 expressed a strong adhesive ability of more than 40 
yeast cells adhering to the monolayer.
Molecular characterization
The yeast isolate OBS2 has 96% identity and query cov-
ers 97% and E value is zero with Saccharomyces cerevi-
siae (Fig. 5b), whereas OBS1 has 100% identity and query 
covers 68% and E value is zero with Pichia kudriavzevii 
(Fig.  5a). The 1370 and 822 base length gene sequences 
of OBS1 and OBS2 isolates were deposited in the NCBI-
GenBank data library and acquired accession number 
KP998094 for S. cerevisiae OBS2 and KP998095 for P. 
kudriavzevii OBS1. These two yeast isolates were used 
for assessment of therapeutic properties.
Therapeutic properties
Out of the two tested yeast samples, sample pertaining to 
yeast isolate OBS2 resulted in a slight reduction in per-
centage cell viability of neuroblastoma cell line IMR32 
(Fig.  6b) but no reduction in percentage cell viability of 
breast cancer cell line MCF7 (Fig. 6a) when compared to 
the control and YPD broth.
The autolysate of yeast isolate OBS1 has shown 
decreased absorbance i.e. 1.799, 1.685 and 1.542 at 
695  nm with the increased concentration of autolysate 
i.e. 0.1, 0.2 and 0.3  ml and it was higher than the posi-
tive control where it showed 1.642 at 0.3 ml concentra-
tion of ascorbic acid. This indicates no antioxidant 
property. Whereas the autolysate of yeast isolate OBS2 
showed increased absorbance i.e. 1.344, 1.454 and 1.528 
at 695 nm with the increased concentration of autolysate 
i.e. 0.1, 0.2 and 0.3 ml and it was lesser than the positive 
control indicates it has antioxidant property.
Discussion
Culturally and morphologically characterized yeast iso-
lates were resistant to majority of the antibacterial drugs, 
because of their cell wall composition which differs with 
Fig. 2 Antagonistic activity of yeast isolates 1 OBS1, 2 OBS2, 3 OBS3, 4 OBS4, 5 OBS7, 6 OBS9, 7 OBS12 and 8 S. boulardii on human intestinal patho-
gens a Escherichia coli 0157:H7, b Pseudomonas aeruginosa, c Klebsiella pneumonia, d Staphylococcus aureus, e Salmonella typhi and f Salmonella 
paratyphi
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prokaryotes (Czerucka et  al. 2007) and most of the iso-
lates were sensitive towards maximum antifungal drugs 
(Mashad et al. 2012).
Antagonistic activity was observed for 24 h grown but 
not 12  h grown yeast isolates against human intestinal 
pathogens. When they cultured in a mixed population 
of intestinal commensals, these isolates showed maxi-
mum co-cultural activity (Izadnia et al. 1998; Filho-Lima 
et  al. 2000; Czerucka and Rampal 2002). Antagonistic 
activity of yeast isolates may be due to the production 
of antimicrobial metabolites (Hatoum et  al. 2012; Rao 
et al. 2009). The present findings of antagonistic and co-
cultural properties of yeast isolates are in accordance 
with Verna and Lucak (2010). The yeast isolates OBS1 
and OBS2 were resilient to gastrointestinal parameters 
is acceptable, when compared with the findings of Kuhle 
et al. (2005), Bhima et al. (2010), Rajkowska and Kunicka-
Styczynska (2010).
The yeast isolates OBS1 and OBS2 did not show 
any pathogenic properties and hence confirmed as 
Fig. 3 Pathogenicity of yeast isolates and commercial probiotic S. boulardii: a protease activity, b phospholipase activity and c haemolytic activity
Fig. 4 Pathogenicity of yeast isolates based on gene amplification: a genomic DNA of the yeast isolates and b amplicons of yeast isolates
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non-pathogens and which is in accordance with the 
reports of Koehn (1982), Manns et al. (1994), Luo et al. 
(2001) and Lechuga et al. (2016). Similarly, these isolates 
have shown strong adhesive property to human intestinal 
cells (Caco-2). This finding is in accordance with Zivko-
vic et al. (2015), where the probiotic organism adhesion is 
more than 40 cells to intestinal cells (Caco-2).
Yeast isolates OBS1 and OBS2 were characterized 
based on phylogenetic analysis as P. kudriavzevii and S. 
cerevisiae. Among the two yeast isolates, OBS2 has a little 
cytotoxic effect on Neuroblastoma cell line IMR32 which 
means continuous use of the isolate OBS2 as probiotics 
may help in curing the incidence of neuroblastoma can-
cer. On the other hand the same isolate OBS2 has an anti-
oxidant property and by increased cell concentration may 
improve its probiotic efficiency, which is in agreement 
with the findings of Naylin et  al. (2005) and Oh et  al. 
(2002).
Based on resilience properties to gastrointestinal 
parameters, antimicrobial agents sensitivity, antagonis-
tic activity, pathogenicity, co-cultural activity, adherence 
ability to intestinal epithelial cells, 2 yeast isolates were 
Fig. 5 Phylogenetic dendrogram of yeast isolates a P. kudriavzevii OBS1 and b S. cerevisiae OBS2
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selected and characterized as P. kudriavzevii OBS1 and 
S. cerevisiae OBS2. Of the two isolates S. cerevisiae OBS2 
has cytotoxic effect on cancer cells and antioxidant activ-
ity hence can be used for human probiotic and therapeu-
tic applications.
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